Rare diseases
Investigational molecules
Locations
Back to France478 clinical trials in Bron, France across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
FranceStudy of DBV712 skin patch safety in children aged 1-3 years with peanut allergy
FranceStudy of zoldonrasib in patients with RAS G12D mutation non-small cell lung cancer who have received previous treatment
FranceStudy of ritlecitinib for treating severe alopecia areata in children aged 6 to under 12 years
FranceStudy of fampridine treatment for patients with spinocerebellar ataxia SCA27B caused by FGF14 gene mutation
FranceLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
FranceStudy comparing valemetostat tosylate plus pembrolizumab versus pembrolizumab alone in patients with advanced non-small cell lung cancer with high PD-L1 expression
FranceStudy of laroprovstat (AZD0780) tablets to lower cholesterol levels in adults with inherited high cholesterol condition (heterozygous familial hypercholesterolemia)
FranceStudy of pelacarsen and inclisiran in patients with atherosclerotic cardiovascular disease who have high levels of LDL cholesterol and lipoprotein(a)
FranceStudy comparing empasiprubart versus intravenous immunoglobulin for treating adults with multifocal motor neuropathy
FranceStudy on the Effectiveness of BP1.4979 for Adults with Essential Tremor
FranceTitle: Study of LP352 (bexicaserin) oral solution versus placebo for treating seizures in children and adults with Developmental and Epileptic Encephalopathies
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple sclerosis and Parkinson's disease, including advanced PET imaging studies and evaluation of novel therapeutic approaches.
Studies include neuroinflammation assessment and serotonergic receptor expression analysis.
Comprehensive research into glioblastoma treatment approaches, combining innovative therapies with standard protocols.
Integration of radiotherapy, chemotherapy, and novel therapeutic agents for improved patient outcomes.
Targeted research on rare conditions including Dravet Syndrome and Alagille syndrome, focusing on innovative therapeutic approaches.
Emphasis on developing effective treatments for previously undertreated rare conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
